[ET Net News Agency, 2 May 2025] REMEGEN (09995) rose 9.9% to HK$41.8.
It hits an intra-day high of HK$41.9, and an intra-day low of HK$37.15. The total shares
traded was 1.67 million, with a value of HK$66.85m. The active buy/sell ratio is 71:29,
with net buying turnover of HK$26.27m. BARCLAYS CAPITAL ASIA accounts for greatest net
responsive buying turnover of HK$1.85m, with volume weighted average price of HK$40.558.
BOCI SEC accounts for greatest net responsive selling turnover of HK$7.93m, with volume
weighted average price of HK$38.025. The stock has risen a combined 13.1% over the past 2
consecutive trading days.

Basic Information
=================

----------------------------------
Nominal 41.800 % Chg +9.86%
High 41.900 Low 37.150
Shares Tr 1.67m Turnover 66.85m
10-D SMA 38.255 %H.V 138.534
20-D SMA 32.742 VWAP 40.124
50-D SMA 24.102 RSI14 68.132
----------------------------------
Status: Active buy/sell ratio is 71:29, with net buying turnover of HK$26.27m, rising a
combined 13.1% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
REMEGEN (09995) 41.80 +9.86
INNOVENT BIO (01801) 55.15 +2.60
XTALPI (02228) 5.04 -2.33
WUXI XDC (02268) 38.00 +3.97
WUXI BIO (02269) 23.75 +4.17
WUXI APPTEC (02359) 63.40 +5.40
TYK MEDICINES-B (02410) 30.80 +6.57
BEIGENE (06160) 151.20 -4.30
AKESO (09926) 88.80 +2.96
ALPHAMAB-B (09966) 7.90 +22.29
-----------------------------------------------
(ed)